Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1972-08-07
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Non GLP and non-guideline compliant study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1972
Report date:
1972
Reference Type:
publication
Title:
Bronidox, a new preserving agent for the cosmetics: properties and toxicological-dermatological assays
Author:
M. Potokar, et al.
Year:
1976
Bibliographic source:
Fette, Seifen, Anstrichmittel, Jahrgang 78, Nr. 7, 269-276
Reference Type:
publication
Title:
Unnamed
Year:
1977
Reference Type:
publication
Title:
Final Report on the Safety Assessment of 5-Bromo-5-Nitro-1,3-Dioxane
Author:
Anonymous (Cosmetic Ingredient Review 10)
Year:
1990
Bibliographic source:
Journal of the American College of Toxicology, Volume 9, Number 2

Materials and methods

Test guideline
Qualifier:
no guideline followed
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
5-bromo-5-nitro-1,3-dioxane
EC Number:
250-001-7
EC Name:
5-bromo-5-nitro-1,3-dioxane
Cas Number:
30007-47-7
Molecular formula:
C4H6BrNO4
IUPAC Name:
5-bromo-5-nitro-1,3-dioxane

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 157 g (mean value)

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
olive oil
Remarks:
heated
Details on exposure:
Injection volume: 20 mL/kg
Doses:
10, 15.8, 19.9, 25.1, 31.6, 39.8, 50.1, 100 mg/kg
No. of animals per sex per dose:
10
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Examinations performed: clinical signs

Results and discussion

Effect levels
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
31.5 mg/kg bw
Based on:
test mat.
Mortality:
10 mg/kg: 0/ 10
15.8 mg/kg: 0/ 10
19.9 mg/kg: 1/ 10
25.1 mg/kg: 4/ 10
31.6 mg/kg: 6/ 10
39.8 mg/kg: 7/ 10
50.1 mg/kg: 8/ 10
100 mg/kg: 10/ 10

Mortality was oberserved after 4 hours - 6 days
Clinical signs:
Observation at 10 mg/kg bw and above:
Decreased and accelerated breathing, staggering, after 2 days extreme nerve symptoms (agitation, shaking, rotation movement)
Body weight:
Not examined

Applicant's summary and conclusion